CN107158323A - A kind of Chinese medicine for treating chronic type b icteric hepatitis - Google Patents

A kind of Chinese medicine for treating chronic type b icteric hepatitis Download PDF

Info

Publication number
CN107158323A
CN107158323A CN201710448514.7A CN201710448514A CN107158323A CN 107158323 A CN107158323 A CN 107158323A CN 201710448514 A CN201710448514 A CN 201710448514A CN 107158323 A CN107158323 A CN 107158323A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
icteric hepatitis
chronic type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710448514.7A
Other languages
Chinese (zh)
Inventor
侯辰阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710448514.7A priority Critical patent/CN107158323A/en
Publication of CN107158323A publication Critical patent/CN107158323A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine for treating chronic type b icteric hepatitis, it is made up of the bulk drug of following weight proportion：25 30 parts of Radix Codonopsis, 30 35 parts of the Radix Astragali, 9 12 parts of radix bupleuri, 20 30 parts of root tuber of aromatic turmeric, 12 18 parts of the membrane of a chicken's gizzard, 20 24 parts of the radix paeoniae rubrathe, 15 21 parts of desmodium, 15 18 parts of giant knotweed, 24 30 parts of oriental wormwood, 20 24 parts of field pennycress, 18 24 parts of isatis root, 30 35 parts of Yun Ling, burnt bent 15 20 parts, 36 parts of radix glycyrrhizae, 6 12 parts of cape jasmine；Medication of the present invention rationally, compatibility science, from above medicinal material, with invigorating the spleen, soothing the liver, promoting blood circulation, cool blood, heat-clearing, removing toxic substances, removing jaundice, clearing damp drug combination, it is straight in this interpretation of the cause, onset and process of an illness, disease position, treat both principal and secondary aspect of disease.

Description

A kind of Chinese medicine for treating chronic type b icteric hepatitis
Technical field
The invention belongs to technical field of traditional Chinese medicines, more particularly to a kind of Chinese medicine for treating chronic type b icteric hepatitis.
Background technology
Chronic type b icteric hepatitis is clinical Gastroenterology dept., Infectious Disease's common disease, is that one kind of chronic hepatitis B is clinical Type, its hepatitis jaundice is deep, and the course of disease is long, and removing jaundice is difficult.China there are about 93,000,000 Chronic Patients with HBV Infection at present according to statistics, its Middle about 20,000,000 be chronic hepatitis B patient, there are about quite a few crowd and occurs that icteric is showed, this is due to hepatitis B It is viral frequently to be replicated in liver for a long time, NK（NK）, cytotoxic T cell（TC）And antibody dependent type lymph is thin Immunological effects occur for three kinds of lymphocytes of born of the same parents, cause liver cell oedema, denaturation, it is downright bad while with bile capillaries silt courage and The formation of courage bolt, thus cause choleresis, bile capillaries, small bile duct obstruction in excretory function obstacle and liver, there is jaundice table It is existing.This sick treatment, modern medicine is more with liver protection and adrenocortical hormones in treating, but contraindication is more, and prolonged application is easily produced Raw serious side effects.
Chronic type b icteric hepatitis belongs to the category of the traditional Chinese medical science " jaundice " disease, patient clinically often shows as that body is yellow, mesh is yellow, Yellow urine, wherein being common clinical, frequently-occurring disease especially with mesh Huang for this sick principal character.Theory of traditional Chinese medical science thinks, the jaundice interpretation of the cause, onset and process of an illness Key is toxic dampness and heat invasion and attack liver and gall, and ferritic is insufficiency of the spleen in addition, and disease enters network long, and channels is obstructed, blood-stasis internal-depression courage internal organs and make bile not Xun Chang roads, overflow in skin outside arteries and veins therefore occur jaundice, treatment when using clearing heat and detoxicating, removing dampness through diuresis and removing jaundice, promoting blood circulation and removing blood stasis, invigorating spleen and soothing liver as It is main.
The content of the invention
In order to solve the above problems, the invention provides a kind of Chinese medicine for treating chronic type b icteric hepatitis, according to slow Property B-mode icteric hepatitis " accumulateing in stagnation of liver-QI with deficiency of the spleen, hot and humid ecchymosis " pathogenic characteristic, develop prescription of the present invention.Medication of the present invention is closed Reason, compatibility science, from above medicinal material, with invigorating the spleen, soothing the liver, promoting blood circulation, cool blood, heat-clearing, removing toxic substances, removing jaundice, clearing damp drug combination, directly Middle the sick interpretation of the cause, onset and process of an illness, sick position, treat both principal and secondary aspect of disease.
The present invention is achieved through the following technical solutions, and the present invention provides a kind of chronic type b icteric hepatitis for the treatment of Chinese medicine, is made up of the bulk drug of following weight proportion：25-30 parts of Radix Codonopsis, 30-35 parts of the Radix Astragali, 9-12 parts of radix bupleuri, root tuber of aromatic turmeric 20-30 Part, 12-18 parts of the membrane of a chicken's gizzard, 20-24 parts of the radix paeoniae rubrathe, 15-21 parts of desmodium, 15-18 parts of giant knotweed, 24-30 parts of oriental wormwood, field pennycress 20- 24 parts, 18-24 parts of isatis root, 30-35 parts of Yun Ling, burnt 15-20 parts of song, 3-6 parts of radix glycyrrhizae, 6-12 parts of cape jasmine.
It is further preferred that the bulk drug composition of the weight proportion is：It is 25 parts of Radix Codonopsis, 30 parts of the Radix Astragali, 9 parts of radix bupleuri, strongly fragrant 20 parts of gold, 12 parts of the membrane of a chicken's gizzard, 20 parts of the radix paeoniae rubrathe, 15 parts of desmodium, 15 parts of giant knotweed, 24 parts of oriental wormwood, 20 parts of field pennycress, isatis root 18 Part, 30 parts of Yun Ling, burnt bent 15 parts, 3 parts of radix glycyrrhizae, 6 parts of cape jasmine.
It is further preferred that the bulk drug composition of the weight proportion is：It is 30 parts of Radix Codonopsis, 35 parts of the Radix Astragali, 12 parts of radix bupleuri, strongly fragrant 30 parts of gold, 18 parts of the membrane of a chicken's gizzard, 24 parts of the radix paeoniae rubrathe, 21 parts of desmodium, 18 parts of giant knotweed, 30 parts of oriental wormwood, 24 parts of field pennycress, isatis root 24 Part, 35 parts of Yun Ling, burnt bent 20 parts, 6 parts of radix glycyrrhizae, 12 parts of cape jasmine.
It is further preferred that the bulk drug composition of the weight proportion is：It is 28 parts of Radix Codonopsis, 33 parts of the Radix Astragali, 11 parts of radix bupleuri, strongly fragrant 25 parts of gold, 15 parts of the membrane of a chicken's gizzard, 22 parts of the radix paeoniae rubrathe, 18 parts of desmodium, 16 parts of giant knotweed, 27 parts of oriental wormwood, 22 parts of field pennycress, isatis root 21 Part, 33 parts of Yun Ling, burnt bent 17 parts, 4 parts of radix glycyrrhizae, 9 parts of cape jasmine.
It is further preferred that the formulation of the Chinese medicine for the treatment of chronic type b icteric hepatitis is decoction.
It is further preferred that the formulation of the Chinese medicine for the treatment of chronic type b icteric hepatitis is pulvis.
It is further preferred that the formulation of the Chinese medicine for the treatment of chronic type b icteric hepatitis is pill.
In the prescription of the present invention, Radix Codonopsis, the Radix Astragali replenish qi to invigorate the spleen, and treat " insufficiency of the spleen " of the sheet of this disease morbidity；Radix bupleuri, root tuber of aromatic turmeric Soothing the liver, Xie Yu, wherein root tuber of aromatic turmeric also have the effect of row stasis of blood cholagogic；Radix paeoniae rubrathe promoting blood circulation and cooling blood, neutralizing ecchymosis；Desmodium, giant knotweed, oriental wormwood profit Courage removing jaundice, clearing away heat and eliminating dampeness poison；Field pennycress, Radix Isatidis, cape jasmine are clearing heat and detoxicating；Cloud Siberian cocklebur invigorating the spleen excreting dampness；The membrane of a chicken's gizzard, Jiao's Qu Jianyun spleens Gas, helps digestion；Radix glycyrrhizae coordinating the drug actions of a prescription.
This sick pathogenic factor B virus, meets Wu Youke《Pestilence opinion》In " miscellaneous gas " cause a disease the characteristics of.With regard to B-mode jaundice For the regularity of disease development and clinical characters of type hepatitis, " miscellaneous gas " is materiality, and property belongs to wet poison.This sick disease located in liver Spleen, its overall interpretation of the cause, onset and process of an illness is：Ferritic is insufficiency of the spleen, " miscellaneous gas " invasion, accumulate in wet poison, liver and spleen is with disease.And wet poison is sticked together, in long aggressiveness not Change, lesion is by spleen weakness, liver dysfunction, the insufficiency of the spleen with overabundance of dampness, the liver warm blood stasis of blood, wet poison is flourishing, disturbs and seeks into blood.Sick venation block long, It is raw in hemostasis, thus gas, blood, phlegm, it is wet mutually accumulate in the costal region, later stage formation bulging, the deficiency of liver-yin and kidney-yin, insufficiency of both the spleen and the kindey etc..The hair of lesion Exhibition be by gas and blood, by sun and it is cloudy, by it is middle it is burnt arrive lower Jiao, or even hematozemia, the evolution process for moving blood, the heresy of " wet poison " runs through simultaneously In disease all the time.
Compared with prior art the beneficial effects of the invention are as follows：
Medication of the present invention rationally, compatibility science, from above medicinal material, with invigorating the spleen, soothing the liver, promoting blood circulation, cool blood, heat-clearing, detoxify, move back Yellow, clearing damp drug combination, it is straight in this interpretation of the cause, onset and process of an illness, sick position, treat both principal and secondary aspect of disease.
Embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiments, to the present invention It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to Limit the present invention.
The application principle of the present invention is further described with reference to specific embodiment.
Prescription embodiment 1, a kind of Chinese medicine for treating chronic type b icteric hepatitis, by the bulk drug group of following weight proportion Into：25 parts of Radix Codonopsis, 30 parts of the Radix Astragali, 9 parts of radix bupleuri, 20 parts of root tuber of aromatic turmeric, 12 parts of the membrane of a chicken's gizzard, 20 parts of the radix paeoniae rubrathe, 15 parts of desmodium, giant knotweed 15 Part, 24 parts of oriental wormwood, 20 parts of field pennycress, 18 parts of isatis root, 30 parts of Yun Ling, burnt bent 15 parts, 3 parts of radix glycyrrhizae, 6 parts of cape jasmine.
Per d1 agent, decocting 2 times takes juice 300mL, taken in two times, it is early before the meal, each 1 time, each 150mL after dinner.
Prescription embodiment 2, a kind of Chinese medicine for treating chronic type b icteric hepatitis, by the bulk drug group of following weight proportion Into：30 parts of Radix Codonopsis, 35 parts of the Radix Astragali, 12 parts of radix bupleuri, 30 parts of root tuber of aromatic turmeric, 18 parts of the membrane of a chicken's gizzard, 24 parts of the radix paeoniae rubrathe, 21 parts of desmodium, giant knotweed 18 Part, 30 parts of oriental wormwood, 24 parts of field pennycress, 24 parts of isatis root, 35 parts of Yun Ling, burnt bent 20 parts, 6 parts of radix glycyrrhizae, 12 parts of cape jasmine.
Per d1 agent, decocting 2 times takes juice 300mL, taken in two times, it is early before the meal, each 1 time, each 150mL after dinner.
Prescription embodiment 3, a kind of Chinese medicine for treating chronic type b icteric hepatitis, by the bulk drug group of following weight proportion Into：28 parts of Radix Codonopsis, 33 parts of the Radix Astragali, 11 parts of radix bupleuri, 25 parts of root tuber of aromatic turmeric, 15 parts of the membrane of a chicken's gizzard, 22 parts of the radix paeoniae rubrathe, 18 parts of desmodium, giant knotweed 16 Part, 27 parts of oriental wormwood, 22 parts of field pennycress, 21 parts of isatis root, 33 parts of Yun Ling, burnt bent 17 parts, 4 parts of radix glycyrrhizae, 9 parts of cape jasmine.
Per d1 agent, decocting 2 times takes juice 300mL, taken in two times, it is early before the meal, each 1 time, each 150mL after dinner.
Clinical test
1st, clinical data：
During the clinical diagnosis and treatment of nearly 3 years numerous chronic type b icteric hepatitis " retention of damp-heat in the interior " patients, " this prescription is completed Chb is treated in agent（Icteric）Clinical observation " city-level scientific research task research, altogether treat 566.
2nd, criterion of therapeutical effect：
Effectively, symptom improves substantially, and jaundice index gradually tends to be normal；
Invalid, symptom is without any improvement or has the trend of deterioration.
3rd, treatment results：It the results are shown in Table 1
The medicine composite for curing of table 1 insomnia curative effect
Effectively It is invalid Total effective rate %
Pharmaceutical composition 496 70 87.6
Through statistics, reach that clinical responder there are 496, invalid 70, overall efficiency reaches 87.6%.Security 100%.
4th, model case
Model case one：Ms Zhang, 45 years old, company clerk had found hepatitis B virus infection 6 years.Nearly two weeks come it is nauseous, detest it is greasy, Indigestion and loss of appetite, dry is bitter, weak, yellow urine such as tea.Nearly one week come find appearance turn to be yellow, body, which slightly feels to disturb, itches, the miserable discomfort of eyes, mood It is easily irritable.April 12 in 2016, Lai LINYI PEOPLE'S HOSPITALs Infectious Disease went to a doctor.Have a medical check-up：Total bilirubin 224mmol/l, Gu Bingzhuan Ammonia enzyme 440u/l.Body mesh xanthochromia, red tongue with yellowish fur is slightly greasy, wiry and rolling pulse.Doctor trained in Western medicine is diagnosed：Chronic type b icteric hepatitis（Acute hair Make）, tcm diagnosis：Jaundice（Accumulate in hot and humid ecchymosis, syndrome of stagnation of liver qi and spleen deficiency）.Treatment, which is given, sentences present patent application decoction plus-minus, 15 There is an improvement after agent, jaundice drops to 150mmol/l in progressive, then take 20 doses, symptom improves substantially, and jaundice index gradually becomes In normal.Follow-up stable disease always afterwards.
Model case two：Zhao so-and-so, man, 29 years old, clinic case.First visit on July 5 in 2012：Tell " hepatitis B " for many years, recently In Linyi Yishui, local hospital is checked, has " change of liver parenchyma echo thickening ", transaminase increases, and bilirubin is high.Have it is weak, receive Difference, abdominal distension, appearance are all yellow, and urine is yellow, and tongue is red, yellow and greasy fur, thready,rolling and rapid pulse.It is dialectical：It is damp and hot strongly fragrant to hold back jaundice.Therapy：Clearing away heat and eliminating dampeness, Soothing liver and strengthening spleen.The decoction of medicinal ingredients with the present application, 1 dose of day are controlled, decocting is divided to two clothes, advises alcohol prohibition of taking things easy.20 days two July in 2012 examines： All diseases have improvement, but symptom of digestive tract is still obvious, are still added and subtracted with front.The 3rd examines after first quarter moon, and symptom and Index for examination gradually delay Solution.
Although the embodiment of the present invention is described above-described embodiment, not to invention protection domain Limitation, one of ordinary skill in the art should be understood that on the basis of the technical scheme of invention those skilled in the art need not pay Go out various modifications or deform still within the scope of the present invention that creative work can make.

Claims (7)

1. a kind of Chinese medicine for treating chronic type b icteric hepatitis, it is characterised in that be made up of the bulk drug of following weight proportion： 25-30 parts of Radix Codonopsis, 30-35 parts of the Radix Astragali, 9-12 parts of radix bupleuri, 20-30 parts of root tuber of aromatic turmeric, 12-18 parts of the membrane of a chicken's gizzard, 20-24 parts of the radix paeoniae rubrathe, money Careless 15-21 parts, 15-18 parts of giant knotweed, 24-30 parts of oriental wormwood, 20-24 parts of field pennycress, 18-24 parts of isatis root, 30-35 parts of Yun Ling, Jiao Bent 15-20 parts, 3-6 parts of radix glycyrrhizae, 6-12 parts of cape jasmine.
2. the Chinese medicine for the treatment of chronic type b icteric hepatitis according to claim 1, it is characterised in that the weight proportion Bulk drug composition be：25 parts of Radix Codonopsis, 30 parts of the Radix Astragali, 9 parts of radix bupleuri, 20 parts of root tuber of aromatic turmeric, 12 parts of the membrane of a chicken's gizzard, 20 parts of the radix paeoniae rubrathe, desmodium 15 parts, 15 parts of giant knotweed, 24 parts of oriental wormwood, 20 parts of field pennycress, 18 parts of isatis root, 30 parts of Yun Ling, burnt bent 15 parts, 3 parts of radix glycyrrhizae, cape jasmine 6 Part.
3. the Chinese medicine for the treatment of chronic type b icteric hepatitis according to claim 1, it is characterised in that the weight proportion Bulk drug composition be：30 parts of Radix Codonopsis, 35 parts of the Radix Astragali, 12 parts of radix bupleuri, 30 parts of root tuber of aromatic turmeric, 18 parts of the membrane of a chicken's gizzard, 24 parts of the radix paeoniae rubrathe, desmodium 21 parts, 18 parts of giant knotweed, 30 parts of oriental wormwood, 24 parts of field pennycress, 24 parts of isatis root, 35 parts of Yun Ling, burnt bent 20 parts, 6 parts of radix glycyrrhizae, cape jasmine 12 Part.
4. the Chinese medicine for the treatment of chronic type b icteric hepatitis according to claim 1, it is characterised in that the weight proportion Bulk drug composition be：28 parts of Radix Codonopsis, 33 parts of the Radix Astragali, 11 parts of radix bupleuri, 25 parts of root tuber of aromatic turmeric, 15 parts of the membrane of a chicken's gizzard, 22 parts of the radix paeoniae rubrathe, desmodium 18 parts, 16 parts of giant knotweed, 27 parts of oriental wormwood, 22 parts of field pennycress, 21 parts of isatis root, 33 parts of Yun Ling, burnt bent 17 parts, 4 parts of radix glycyrrhizae, cape jasmine 9 Part.
5. the Chinese medicine of the treatment chronic type b icteric hepatitis according to claim any one of 1-4, it is characterised in that its agent Type is decoction.
6. the Chinese medicine of the treatment chronic type b icteric hepatitis according to claim any one of 1-4, it is characterised in that its agent Type is pulvis.
7. the Chinese medicine of the treatment chronic type b icteric hepatitis according to claim any one of 1-4, it is characterised in that its agent Type is pill.
CN201710448514.7A 2017-06-14 2017-06-14 A kind of Chinese medicine for treating chronic type b icteric hepatitis Pending CN107158323A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710448514.7A CN107158323A (en) 2017-06-14 2017-06-14 A kind of Chinese medicine for treating chronic type b icteric hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710448514.7A CN107158323A (en) 2017-06-14 2017-06-14 A kind of Chinese medicine for treating chronic type b icteric hepatitis

Publications (1)

Publication Number Publication Date
CN107158323A true CN107158323A (en) 2017-09-15

Family

ID=59818519

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710448514.7A Pending CN107158323A (en) 2017-06-14 2017-06-14 A kind of Chinese medicine for treating chronic type b icteric hepatitis

Country Status (1)

Country Link
CN (1) CN107158323A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886666A (en) * 1987-01-27 1989-12-12 Yaguang Liu Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
CN1233487A (en) * 1998-04-24 1999-11-03 汪东平 Medicine for treating hepatitis B
CN101757433A (en) * 2009-11-02 2010-06-30 泰一和浦（北京）中医药研究院有限公司 Traditional Chinese medicine composition for treating acute hepatitis and preparation method thereof
CN104940828A (en) * 2015-06-30 2015-09-30 任晓明 Traditional Chinese medicine composition for treating viral hepatitis and preparation method of traditional Chinese medicine composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886666A (en) * 1987-01-27 1989-12-12 Yaguang Liu Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
CN1233487A (en) * 1998-04-24 1999-11-03 汪东平 Medicine for treating hepatitis B
CN101757433A (en) * 2009-11-02 2010-06-30 泰一和浦（北京）中医药研究院有限公司 Traditional Chinese medicine composition for treating acute hepatitis and preparation method thereof
CN104940828A (en) * 2015-06-30 2015-09-30 任晓明 Traditional Chinese medicine composition for treating viral hepatitis and preparation method of traditional Chinese medicine composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
尤企明: "清肝化淤汤治疗黄疸型肝炎54例观察", 《实用中医药杂志》 *

Similar Documents

Publication Publication Date Title
CN101274087B (en) Chinese medicine decoction for invigorating gallbladder and removing gall-stone
CN103638334B (en) Oral liquid for anemofrigid-damp arthralgia and preparation method thereof
CN102872359B (en) Traditional Chinese medicine composition for treating chronic cholecystitis
CN103948782B (en) Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition
CN101254286B (en) Chinese medicinal composition for curing wind dampness and rheumatoid
CN103908600B (en) The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method
CN103405653B (en) External preparation for treating gouty arthritis
CN102380011B (en) Traditional Chinese medicine composition for treating polyarteritis nodosa
CN107158323A (en) A kind of Chinese medicine for treating chronic type b icteric hepatitis
CN102949665A (en) Pure traditional Chinese medical composition for cholagogue and urinary calculus removal as well as preparation method thereof
CN103495061B (en) Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis
CN103463578B (en) Medicament for treating cholelithiasis, cholecystitis and hyperbilirubinemia
CN106110124A (en) A kind of antituberculotic Chinese medicine composition
CN105497656A (en) Efficient medicinal liquor for treating gout
CN104161996A (en) Combined medicine for treating traumatic injury and preparation method of combined medicine
CN103169832A (en) Traditional Chinese medicine for treating polyarteritis nodosa
CN103007186A (en) Chinese medicinal formulae used for treating increase of jaundice
CN102631481B (en) Chinese medicinal preparation for treating viral hepatitis
CN102988915B (en) Hip bath lotion for treating haemorrhoid
CN105963456B (en) A Chinese medicinal composition for treating ascites due to liver cirrhosis and hepatitis B, and its preparation method
CN109663081B (en) Zhuang medicine composition for treating functional unsmooth urination of bladder and preparation method thereof
CN105617347A (en) Traditional Chinese medicine composition for treating chronic nephritis
CN105998842A (en) Traditional Chinese medicine preparation for treating cholecystitis due to qi stagnation and blood stasis
CN104689253A (en) Traditional Chinese medicine composition for treating gallbladder removal syndromes
CN103251669B (en) Anti-hepatic fibrosis drug composite

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170915